首页 正文

From concept to clinical practice: the evolution of low- and ultra-low-dose triple combination therapy for hypertension

{{output}}
Hypertension remains a leading contributor to global cardiovascular (CV) morbidity and mortality, yet blood pressure (BP) control rates remain suboptimal worldwide. Therapeutic inertia, delayed treatment intensification, dose-dependent adverse effects, and lim... ...